Despite these controversial results, to the best our knowledge, no study has attempted to evaluate the association of serum VCAM-1 with cardiovascular risk in patients without acute coronary syndrome, thus supporting the needed for new studies. The gene discussed is VCAM1; the disease is acute coronary syndrome.